about
Current and emerging therapeutic options in adrenocortical cancer treatment.Is there a role of targeted agents in the management of adrenocortical cancers?Establishment and characterization of the first pediatric adrenocortical carcinoma xenograft model identifies topotecan as a potential chemotherapeutic agentmRNA and microRNA expression patterns in adrenocortical cancer.rac-2-[(2-Chloro-phen-yl)(4-chloro-phen-yl)meth-yl]-1,3-dioxolane.Common module analysis reveals prospective targets and mechanisms of pediatric adrenocortical adenoma and carcinoma.
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Therapy of adrenocortical cancer: present and future.
@ast
Therapy of adrenocortical cancer: present and future.
@en
type
label
Therapy of adrenocortical cancer: present and future.
@ast
Therapy of adrenocortical cancer: present and future.
@en
prefLabel
Therapy of adrenocortical cancer: present and future.
@ast
Therapy of adrenocortical cancer: present and future.
@en
P2093
P2860
P1476
Therapy of adrenocortical cancer: present and future
@en
P2093
Brás H de Oliveira
Daniela F Maluf
Enzo Lalli
P2860
P304
P577
2010-12-07T00:00:00Z